| XBIT Stock | | | USD 7.61 0.26 3.54% |
XBiotech financial indicator trend analysis is more than just analyzing XBiotech current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XBiotech is a good investment. Please check the relationship between XBiotech Accounts Payable and its Total Stockholder Equity accounts. Check out
Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
For more information on how to buy XBiotech Stock please use our
How to Invest in XBiotech guide.
Accounts Payable vs Total Stockholder Equity
Accounts Payable vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
XBiotech Accounts Payable account and
Total Stockholder Equity. At this time, the significance of the direction appears to have very week relationship.
The correlation between XBiotech's Accounts Payable and Total Stockholder Equity is 0.24. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of XBiotech, assuming nothing else is changed. The correlation between historical values of XBiotech's Accounts Payable and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of XBiotech are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Accounts Payable i.e., XBiotech's Accounts Payable and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.24 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents XBiotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of XBiotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from XBiotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XBiotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
For more information on how to buy XBiotech Stock please use our
How to Invest in XBiotech guide.At this time, XBiotech's
Selling General Administrative is comparatively stable compared to the past year.
Sales General And Administrative To Revenue is likely to gain to 1.49 in 2024, whereas
Tax Provision is likely to drop slightly above 875
K in 2024.
XBiotech fundamental ratios Correlations
Click cells to compare fundamentals
XBiotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
XBiotech fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to
measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to
predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.